Kimura Masahiro, Kuwabara Yoshiyuki, Ishiguro Hideyuki, Tanaka Tatsuya, Takeyama Hiromitsu
Hepatogastroenterology. 2015 Jun;62(140):794-6.
We evaluated the bypass operation as palliation for unresectable esophageal cancer. In this study, patients were divided into 2 groups. Group A included 19 patients with good progress, defined as sufficient oral ingestion for more than 2 months. The other 10 patients were in Group B and had poor progress. Oral ingestion was impossible postoperatively in 2 of 29 cases. Although there is a difference of a grade, other patients could have improvement of quality of life. Patients with no preoperative therapy and patients whose nutrient state was maintained comparatively well had a good adaptation after bypass surgery. We concluded that if the surgeon chooses the patients carefully, bypass is a very useful operative method.
我们评估了旁路手术作为不可切除食管癌姑息治疗的效果。在本研究中,患者被分为两组。A组包括19例进展良好的患者,定义为口服摄入充足超过2个月。另外10例患者在B组,进展较差。29例中有2例术后无法经口摄入。尽管存在一个等级的差异,但其他患者的生活质量可以得到改善。未接受术前治疗且营养状态相对维持良好的患者在旁路手术后适应性良好。我们得出结论,如果外科医生仔细选择患者,旁路手术是一种非常有用的手术方法。